Top compounds associated with response to LMO3


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel gCSI pan-cancer AAC -0.13 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.02
mRNA T0901317 GDSC1000 pan-cancer AAC 0.081 0.02
mRNA TPCA-1 GDSC1000 pan-cancer AAC 0.07 0.02
mRNA JQ12 GDSC1000 pan-cancer AAC -0.085 0.02
mRNA TAK-715 GDSC1000 pan-cancer AAC 0.078 0.02
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC 0.083 0.02
mRNA JW-55 CTRPv2 pan-cancer AAC 0.17 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.079 0.02
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.078 0.02
Download CSV